技术资料
-
R. Gao et al. (dec 2019) Pediatric surgery international 35 12 1363--1368A comparison of exosomes derived from different periods breast milk on protecting against intestinal organoid injury.
AIM OF THE STUDY Human breast milk reduces the risk and severity of necrotizing enterocolitis (NEC). Exosomes are extracellular vesicles (EVs) found in high concentrations in milk,and they mediate intercellular communication and immune responses. The aim of this study is to compare the protective effects of exosomes that are derived from different time periods of breast milk production against intestinal injury using an ex vivo intestinal organoid model. METHODS Colostrum,transitional and mature breast milk samples from healthy lactating mothers were collected. Exosomes were isolated using serial ultracentrifugation and filtration. Exosomes' presence was confirmed using transmission electron microscopy (TEM) and western blot. To form the intestinal organoids,terminal ileum was harvested from neonatal mice pups at postnatal day 9,crypts were isolated and organoids were cultured in matrigel. Organoids were either cultured with exposure to lipopolysaccharide (LPS),or in treatment groups where both LPS and exosomes were added in the culturing medium. Inflammatory markers and organoids viability were evaluated. MAIN RESULTS Human milk-derived exosomes were successfully isolated and characterized. LPS administration reduced the size of intestinal organoids,induced inflammation through increasing TNF$\alpha$ and TLR4 expression,and stimulated intestinal regeneration. Colostrum,transitional and mature human milk-derived exosome treatment all prevented inflammatory injury,while exosomes derived from colostrum were most effective at reducing inflammatory cytokine. CONCLUSIONS Human breast milk-derived exosomes were able to protect intestine organoids against epithelial injury induced by LPS. Colostrum exosomes offer the best protective effect among the breast-milk derived exosomes. Human milk exosomes can be protective against the development of intestinal injury such as that seen in NEC. View Publication -
(Nov 2024) Tomography 10 11A Comparison of the Sensitivity and Cellular Detection Capabilities of Magnetic Particle Imaging and Bioluminescence Imaging
Background: Preclinical cell tracking is enhanced with a multimodal imaging approach. Bioluminescence imaging (BLI) is a highly sensitive optical modality that relies on engineering cells to constitutively express a luciferase gene. Magnetic particle imaging (MPI) is a newer imaging modality that directly detects superparamagnetic iron oxide (SPIO) particles used to label cells. Here,we compare BLI and MPI for imaging cells in vitro and in vivo. Methods: Mouse 4T1 breast carcinoma cells were transduced to express firefly luciferase,labeled with SPIO (ProMag),and imaged as cell samples after subcutaneous injection into mice. Results: For cell samples,the BLI and MPI signals were strongly correlated with cell number. Both modalities presented limitations for imaging cells in vivo. For BLI,weak signal penetration,signal attenuation,and scattering prevented the detection of cells for mice with hair and for cells far from the tissue surface. For MPI,background signals obscured the detection of low cell numbers due to the limited dynamic range,and cell numbers could not be accurately quantified from in vivo images. Conclusions: It is important to understand the shortcomings of these imaging modalities to develop strategies to improve cellular detection sensitivity. View Publication -
Tsuboi S (JUN 2006) Journal of immunology (Baltimore,Md. : 1950) 176 11 6576--85A complex of Wiskott-Aldrich syndrome protein with mammalian verprolins plays an important role in monocyte chemotaxis.
The Wiskott-Aldrich syndrome protein (WASP) is a product of the gene defective in an Xid disorder,Wiskott-Aldrich syndrome. WASP expression is limited to hemopoietic cells,and WASP regulates the actin cytoskeleton. It has been reported that monocytes/macrophages from WASP-deficient Wiskott-Aldrich syndrome patients are severely defective in chemotaxis,resulting in recurrent infection. However,the molecular basis of such chemotactic defects is not understood. Recently,the WASP N-terminal region was found to bind to the three mammalian verprolin homologs: WASP interacting protein (WIP); WIP and CR16 homologous protein (WICH)/WIP-related protein (WIRE); and CR16. Verprolin was originally found to play an important role in the regulation of actin cytoskeleton in yeast. We have shown that WASP,WIP,and WICH/WIRE are expressed predominantly in the human monocyte cell line THP-1 and that WIP and WICH/WIRE are involved in monocyte chemotaxis. When WASP binding to verprolins was blocked,chemotactic migration of monocytes was impaired in both THP-1 cells and primary human monocytes. Increased expression of WASP and WIP enhanced monocyte chemotaxis. Blocking WASP binding to verprolins impaired cell polarization but not actin polymerization. These results indicate that a complex of WASP with mammalian verprolins plays an important role in chemotaxis of monocytes. Our results suggest that WASP and mammalian verprolins function as a unit in monocyte chemotaxis and that the activity of this unit is critical to establish cell polarization. In addition,our results also indicate that the WASP-verprolin complex is involved in other functions such as podosome formation and phagocytosis. View Publication -
Li Y et al. (MAR 2015) PLoS ONE 10 3 e0118266A comprehensive library of familial human amyotrophic lateral sclerosis induced pluripotent stem cells
Amyotrophic lateral sclerosis is a progressive disease characterized by the loss of upper and lower motor neurons,leading to paralysis of voluntary muscles. About 10% of all ALS cases are familial (fALS),among which 15-20% are linked to Cu/Zn superoxide dismutase (SOD1) mutations,usually inherited in an autosomal dominant manner. To date only one FDA approved drug is available which increases survival moderately. Our understanding of ALS disease mechanisms is largely derived from rodent model studies,however due to the differences between rodents and humans,it is necessary to have humanized models for studies of disease pathogenesis as well as drug development. Therefore,we generated a comprehensive library of a total 22 of fALS patient-specific induced pluripotent stem cell (iPSC) lines. These cells were thoroughly characterized before being deposited into the library. The library of cells includes a variety of C9orf72 mutations,sod1 mutations,FUS,ANG and FIG4 mutations. Certain mutations are represented with more than one line,which allows for studies of variable genetic backgrounds. In addition,these iPSCs can be successfully differentiated to astroglia,a cell type known to play a critical role in ALS disease progression. This library represents a comprehensive resource that can be used for ALS disease modeling and the development of novel therapeutics. View Publication -
Park S et al. (APR 2017) Stem cell reports 8 4 1076--1085A Comprehensive, Ethnically Diverse Library of Sickle Cell Disease-Specific Induced Pluripotent Stem Cells.
Sickle cell anemia affects millions of people worldwide and is an emerging global health burden. As part of a large NIH-funded NextGen Consortium,we generated a diverse,comprehensive,and fully characterized library of sickle-cell-disease-specific induced pluripotent stem cells (iPSCs) from patients of different ethnicities,β-globin gene (HBB) haplotypes,and fetal hemoglobin (HbF) levels. iPSCs stand to revolutionize the way we study human development,model disease,and perhaps eventually,treat patients. Here,we describe this unique resource for the study of sickle cell disease,including novel haplotype-specific polymorphisms that affect disease severity,as well as for the development of patient-specific therapeutics for this phenotypically diverse disorder. As a complement to this library,and as proof of principle for future cell- and gene-based therapies,we also designed and employed CRISPR/Cas gene editing tools to correct the sickle hemoglobin (HbS) mutation. View Publication -
(Mar 2024) Nature Communications 15A conserved NR5A1-responsive enhancer regulates
The Y-linked SRY gene initiates mammalian testis-determination. However,how the expression of SRY is regulated remains elusive. Here,we demonstrate that a conserved steroidogenic factor-1 (SF-1)/NR5A1 binding enhancer is required for appropriate SRY expression to initiate testis-determination in humans. Comparative sequence analysis of SRY 5’ regions in mammals identified an evolutionary conserved SF-1/NR5A1-binding motif within a 250 bp region of open chromatin located 5 kilobases upstream of the SRY transcription start site. Genomic analysis of 46,XY individuals with disrupted testis-determination,including a large multigenerational family,identified unique single-base substitutions of highly conserved residues within the SF-1/NR5A1-binding element. In silico modelling and in vitro assays demonstrate the enhancer properties of the NR5A1 motif. Deletion of this hemizygous element by genome-editing,in a novel in vitro cellular model recapitulating human Sertoli cell formation,resulted in a significant reduction in expression of SRY. Therefore,human NR5A1 acts as a regulatory switch between testis and ovary development by upregulating SRY expression,a role that may predate the eutherian radiation. We show that disruption of an enhancer can phenocopy variants in the coding regions of SRY that cause human testis dysgenesis. Since disease causing variants in enhancers are currently rare,the regulation of gene expression in testis-determination offers a paradigm to define enhancer activity in a key developmental process. Disease-causing variants define a conserved and unique NR5A1 responsive enhancer for SRY expression to initiate testis-determination in humans. Modelling regulatory variants causing sex-reversal provides a tool to understand global enhancer activity. View Publication -
(Jun 2025) Cell Reports Methods 5 4A cost- and time-efficient method for high-throughput cryoprocessing and tissue analysis using multiplexed tissue molds
SummaryCryosectioning remains the gold standard for antibody and transcriptomic/in situ hybridization tissue analysis. However,tissue processing is time-consuming and costly,limiting routine and diagnostic use. Currently,no commercially available protocols or products exist for multiplexing this process. Here,we introduce multiplexed tissue molds (MTMs) that enable high-throughput cryoprocessing—cutting costs and workload by up to 96% while permitting the processing of tissues of various sizes and origins. We demonstrate compatibility with heterogeneous tissues by processing 19 different adult mouse tissues in parallel. Furthermore,we process up to ?110 neural organoids of different ages and sizes simultaneously and assess their neural differentiation marker expression. MTMs allow sectioning-based tissue analysis when labor,time,and cost are limiting factors. MTMs could be used to compare high specimen numbers in histopathological settings,organism-wide antigen and antibody targeting studies,high-throughput tissue screens,and defined tissue section positioning for,e.g.,spatial transcriptomics experiments. Graphical abstract Highlights•Multiplexed tissue molds (MTMs) drastically upscale cryosectioning procedures•MTMs can simultaneously accommodate up to 19 mouse organs and ?110 cerebral organoids•MTMs reduce analysis costs and processing times of tissues by up to 96%•MTMs could be used to reduce diagnostic costs and for spatial transcriptomics MotivationEfficient cryosectioning remains a critical yet labor- and cost-intensive step for immunohistochemistry and in situ hybridization,limiting routine diagnostic and research applications. The increasing demand for high-throughput tissue analysis—driven by advances in organoid and three-dimensional (3D) culture systems and tissue analysis for diagnostics—necessitates methods capable of processing numerous heterogeneous samples simultaneously. Current protocols lack multiplexing capabilities,leading to variability and extended processing times. Our work introduces multiplexed tissue molds (MTMs),a scalable solution that drastically reduces costs and labor by up to 96% while maintaining tissue integrity and consistency,thereby enabling large-scale (>100 tissues) comparative analyses and enhanced experimental reproducibility as well as access to tissue analysis,where cost is a restrictive factor. Reumann et al. develop multiplexed tissue molds (MTMs),which allow upscaling of tissue processing (up to 19 mouse organs or ?110 cerebral organoids simultaneously) while reducing workload and associated analysis costs by up to 96%. MTMs allow cryosection-based tissue analysis when labor,time,and cost are limiting factors and could be used for patient sample analysis as well as spatial transcriptomics approaches. View Publication -
Pua HH et al. (JAN 2007) The Journal of experimental medicine 204 1 25--31A critical role for the autophagy gene Atg5 in T cell survival and proliferation.
Macroautophagy (hereafter referred to as autophagy) is a well-conserved intracellular degradation process. Recent studies examining cells lacking the autophagy genes Atg5 and Atg7 have demonstrated that autophagy plays essential roles in cell survival during starvation,in innate cell clearance of microbial pathogens,and in neural cell maintenance. However,the role of autophagy in T lymphocyte development and survival is not known. Here,we demonstrate that autophagosomes form in primary mouse T lymphocytes. By generating Atg5-/- chimeric mice,we found that Atg5-deficient T lymphocytes underwent full maturation. However,the numbers of total thymocytes and peripheral T and B lymphocytes were reduced in Atg5 chimeras. In the periphery,Atg5-/- CD8+ T lymphocytes displayed dramatically increased cell death. Furthermore,Atg5-/- CD4+ and CD8+ T cells failed to undergo efficient proliferation after TCR stimulation. These results demonstrate a critical role for Atg5 in multiple aspects of lymphocyte development and function and suggest that autophagy may be essential for both T lymphocyte survival and proliferation. View Publication -
Chambon P (JUL 1996) FASEB journal : official publication of the Federation of American Societies for Experimental Biology 10 9 940--54A decade of molecular biology of retinoic acid receptors.
Retinoids play an important role in development,differentiation,and homeostasis. The discovery of retinoid receptors belonging to the superfamily of nuclear ligand-activated transcriptional regulators has revolutionized our molecular understanding as to how these structurally simple molecules exert their pleiotropic effects. Diversity in the control of gene expression by retinoid signals is generated through complexity at different levels of the signaling pathway. A major source of diversity originates from the existence of two families of retinoid acid (RA) receptors (R),the RAR isotypes (alpha,beta,and gamma) and the three RXR isotypes (alpha,beta,and gamma),and their numerous isoforms,which bind as RXR/RAR heterodimers to the polymorphic cis-acting response elements of RA target genes. The possibility of cross-modulation (cross-talk) with cell-surface receptors signaling pathways,as well as the finding that RARs and RXRs interact with multiple putative coactivators and/or corepressors,generates additional levels of complexity for the array of combinatorial effects that underlie the pleiotropic effects of retinoids. This review focuses on recent developments,particularly in the area of structure-function relationships. View Publication -
Klim JR et al. (DEC 2010) Nature methods 7 12 989--94A defined glycosaminoglycan-binding substratum for human pluripotent stem cells.
To exploit the full potential of human pluripotent stem cells for regenerative medicine,developmental biology and drug discovery,defined culture conditions are needed. Media of known composition that maintain human embryonic stem (hES) cells have been developed,but finding chemically defined,robust substrata has proven difficult. We used an array of self-assembled monolayers to identify peptide surfaces that sustain pluripotent stem cell self-renewal. The effective substrates displayed heparin-binding peptides,which can interact with cell-surface glycosaminoglycans and could be used with a defined medium to culture hES cells for more than 3 months. The resulting cells maintained a normal karyotype and had high levels of pluripotency markers. The peptides supported growth of eight pluripotent cell lines on a variety of scaffolds. Our results indicate that synthetic substrates that recognize cell-surface glycans can facilitate the long-term culture of pluripotent stem cells. View Publication -
Lu HF et al. (MAR 2014) Biomaterials 35 9 2816--2826A defined xeno-free and feeder-free culture system for the derivation, expansion and direct differentiation of transgene-free patient-specific induced pluripotent stem cells
A defined xeno-free system for patient-specific iPSC derivation and differentiation is required for translation to clinical applications. However,standard somatic cell reprogramming protocols rely on using MEFs and xenogeneic medium,imposing a significant obstacle to clinical translation. Here,we describe a well-defined culture system based on xeno-free media and LN521 substrate which supported i) efficient reprogramming of normal or diseased skin fibroblasts from human of different ages into hiPSCs with a 15-30 fold increase in efficiency over conventional viral vector-based method; ii) long-term self-renewal of hiPSCs; and iii) direct hiPSC lineage-specific differentiation. Using an excisable polycistronic vector and optimized culture conditions,we achieved up to 0.15%-0.3% reprogramming efficiencies. Subsequently,transgene-free hiPSCs were obtained by Cre-mediated excision of the reprogramming factors. The derived iPSCs maintained long-term self-renewal,normal karyotype and pluripotency,as demonstrated by the expression of stem cell markers and ability to form derivatives of three germ layers both in vitro and in vivo. Importantly,we demonstrated that Parkinson's patient transgene-free iPSCs derived using the same system could be directed towards differentiation into dopaminergic neurons under xeno-free culture conditions. Our approach provides a safe and robust platform for the generation of patient-specific iPSCs and derivatives for clinical and translational applications. textcopyright 2013 Elsevier Ltd. View Publication
过滤器
筛选结果
细胞类型
- B 细胞 237 项目
- CD4+ 46 项目
- CD8+ 29 项目
- CHO细胞 19 项目
- HEK-293细胞(人胚肾293细胞) 2 项目
- HUVEC细胞(人脐静脉内皮细胞) 1 项目
- NK 细胞 175 项目
- PSC衍生 43 项目
- T 细胞 453 项目
- 上皮细胞 127 项目
- 中胚层 5 项目
- 乳腺细胞 103 项目
- 先天性淋巴细胞 41 项目
- 全血 8 项目
- 其他子集 1 项目
- 其他细胞系 9 项目
- 内皮细胞 13 项目
- 内皮集落形成细胞(ECFCs) 3 项目
- 内胚层 3 项目
- 前列腺细胞 20 项目
- 单个核细胞 92 项目
- 单核细胞 192 项目
- 多能干细胞 1988 项目
- 小胶质细胞 4 项目
- 巨噬细胞 43 项目
- 巨核细胞 10 项目
- 心肌细胞 20 项目
- 成骨细胞 9 项目
- 星形胶质细胞 7 项目
- 杂交瘤细胞 97 项目
- 树突状细胞(DCs) 132 项目
- 气道细胞 4 项目
- 淋巴细胞 84 项目
- 癌细胞及细胞系 146 项目
- 癌细胞和细胞系 1 项目
- 白细胞 17 项目
- 白细胞单采样本 12 项目
- 白血病/淋巴瘤细胞 14 项目
- 监管 1 项目
- 真皮细胞 2 项目
- 神经元 2 项目
- 神经干/祖细胞 472 项目
- 神经细胞 16 项目
- 粒细胞及其亚群 106 项目
- 红系细胞 12 项目
- 红细胞 12 项目
- 肌源干/祖细胞 10 项目
- 肝细胞 35 项目
- 肠道细胞 90 项目
- 肾细胞 4 项目
- 肿瘤细胞 26 项目
- 胰腺细胞 16 项目
- 脂肪细胞 6 项目
- 脑肿瘤干细胞 101 项目
- 血小板 4 项目
- 血浆 3 项目
- 血管生成细胞 4 项目
- 调节性细胞 11 项目
- 软骨细胞 8 项目
- 造血干/祖细胞 984 项目
- 造血干祖细胞 6 项目
- 造血细胞 4 项目
- 间充质基质细胞 20 项目
- 间充质干/祖细胞 205 项目
- 间充质干祖细胞 1 项目
- 间充质细胞 4 项目
- 骨髓基质细胞 1 项目
- 骨髓间质细胞 1 项目
- 髓系细胞 147 项目
- 肾脏细胞 5 项目
- CD4+T细胞 108 项目
- CD8+T细胞 89 项目
- PSC衍生上皮细胞 30 项目
- PSC衍生中胚层 20 项目
- PSC衍生内皮细胞 12 项目
- PSC衍生内胚层 20 项目
- PSC衍生心肌细胞 21 项目
- PSC衍生神经细胞 117 项目
- PSC衍生肝细胞 11 项目
- PSC衍生造血干细胞 25 项目
- PSC衍生间充质细胞 20 项目
- 其他T细胞亚型 25 项目
- 呼吸道细胞 89 项目
- 多巴胺能神经元 7 项目
- 小鼠胚胎成纤维细胞 1 项目
- 浆细胞 12 项目
- 神经元 193 项目
- 调节性T细胞 65 项目
- 骨髓瘤 5 项目
Show More
Show Less
产品类型
- 仪器及软件
Show More
Show Less
研究领域
- HIV 85 项目
- HLA 60 项目
- 上皮细胞生物学 270 项目
- 上皮细胞研究 3 项目
- 免疫 1034 项目
- 内皮细胞研究 1 项目
- 呼吸系统研究 38 项目
- 嵌合体 30 项目
- 干细胞生物学 2921 项目
- 感染性疾病(传染病) 7 项目
- 抗体制备 6 项目
- 新陈代谢 4 项目
- 杂交瘤制备 3 项目
- 疾病建模 208 项目
- 癌症 7 项目
- 神经科学 665 项目
- 移植研究 106 项目
- 类器官 157 项目
- 细胞外囊泡研究 8 项目
- 细胞治疗开发 18 项目
- 细胞疗法开发 101 项目
- 细胞系制备 187 项目
- 脐带血库 74 项目
- 药物发现和毒理检测 380 项目
- 血管生成细胞研究 1 项目
- 传染病 54 项目
- 内皮细胞生物学 8 项目
- 杂交瘤生成 18 项目
- 癌症研究 710 项目
- 血管生成细胞研究 57 项目
Show More
Show Less
产品系列
- ALDECOUNT 14 项目
- CellPore 10 项目
- CellSTACK 1 项目
- EasyPick 1 项目
- ELISA 3 项目
- ErythroClear 3 项目
- ES-Cult 81 项目
- Falcon 1 项目
- GloCell 1 项目
- GyneCult 1 项目
- HetaSep 1 项目
- iCell 14 项目
- Matrigel 2 项目
- MegaCult 36 项目
- ProstaCult 1 项目
- STEMprep 12 项目
- ALDEFLUOR 238 项目
- AggreWell 85 项目
- ArciTect 37 项目
- BloodStor 3 项目
- BrainPhys 65 项目
- CellAdhere 2 项目
- ClonaCell 112 项目
- CloneR 8 项目
- CryoStor 75 项目
- EC-Cult 2 项目
- EasySep 896 项目
- EpiCult 21 项目
- HemaTox 4 项目
- HepatiCult 25 项目
- Hypothermosol 1 项目
- ImmunoCult 32 项目
- IntestiCult 186 项目
- Lymphoprep 10 项目
- MammoCult 45 项目
- MesenCult 154 项目
- MethoCult 509 项目
- MyeloCult 65 项目
- MyoCult 10 项目
- NaïveCult 1 项目
- NeuroCult 372 项目
- NeuroFluor 3 项目
- PBS-MINI 6 项目
- PancreaCult 11 项目
- PneumaCult 87 项目
- RSeT 13 项目
- ReLeSR 8 项目
- RoboSep 49 项目
- RosetteSep 252 项目
- STEMdiff 165 项目
- STEMscript 1 项目
- STEMvision 7 项目
- SepMate 29 项目
- SmartDish 1 项目
- StemSpan 252 项目
- TeSR 1549 项目
- ThawSTAR 4 项目
- mFreSR 9 项目
- Highway1 7 项目
Show More
Show Less

EasySep™小鼠TIL(CD45)正选试剂盒



沪公网安备31010102008431号